0FP0 Stock Overview
Provides health technology, mobility, and health care products in Spain. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Prim, S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €9.84 |
| 52 Week High | €11.95 |
| 52 Week Low | €9.70 |
| Beta | 0.60 |
| 11 Month Change | -0.20% |
| 3 Month Change | -11.35% |
| 1 Year Change | n/a |
| 33 Year Change | -30.95% |
| 5 Year Change | n/a |
| Change since IPO | 90.28% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0FP0 | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0.8% | -1.5% | 1.0% |
| 1Y | n/a | -1.1% | 6.3% |
Return vs Industry: Insufficient data to determine how 0FP0 performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how 0FP0 performed against the UK Market.
Price Volatility
| 0FP0 volatility | |
|---|---|
| 0FP0 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.0% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.2% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0FP0's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine 0FP0's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1870 | 901 | n/a | www.prim.es |
Prim, S.A. provides health technology, mobility, and health care products in Spain. The company offers collar, clavicle, armsling, hand and finger, shoulder, elbow, and wrist products. Its lower limbs products include calf brace, thigh, hip, knee, ankle, and foot related products.
Prim, S.A. Fundamentals Summary
| 0FP0 fundamental statistics | |
|---|---|
| Market cap | €170.16m |
| Earnings (TTM) | €11.43m |
| Revenue (TTM) | €227.57m |
14.9x
P/E Ratio0.7x
P/S RatioIs 0FP0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0FP0 income statement (TTM) | |
|---|---|
| Revenue | €227.57m |
| Cost of Revenue | €118.54m |
| Gross Profit | €109.02m |
| Other Expenses | €97.60m |
| Earnings | €11.43m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.67 |
| Gross Margin | 47.91% |
| Net Profit Margin | 5.02% |
| Debt/Equity Ratio | 10.7% |
How did 0FP0 perform over the long term?
See historical performance and comparison